0 followers
Trishula Therapeutics is a clinical-stage cancer immunotherapy company developing TTX-030, a first-in-class anti-CD39 antibody.
Industries
Headquarters
Stage
Employees
Links
Anil Singhal
4 members
1 members
Dyno Therapeutics
4 followers
BioMarin Pharmaceutical
21 followers
Adaptive Biotechnologies
11 followers
Agilent Technologies
60 followers
Regeneron
77 followers
Discover companies